These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24456667)

  • 1. Reduced migration of MLH1 deficient colon cancer cells depends on SPTAN1.
    Hinrichsen I; Ernst BP; Nuber F; Passmann S; Schäfer D; Steinke V; Friedrichs N; Plotz G; Zeuzem S; Brieger A
    Mol Cancer; 2014 Jan; 13():11. PubMed ID: 24456667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer.
    Ackermann A; Schrecker C; Bon D; Friedrichs N; Bankov K; Wild P; Plotz G; Zeuzem S; Herrmann E; Hansmann ML; Brieger A
    PLoS One; 2019; 14(3):e0213411. PubMed ID: 30856214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and secretion of the pro‑inflammatory cytokine IL‑8 is increased in colorectal cancer cells following the knockdown of non‑erythroid spectrin αII.
    Ackermann A; Lafferton B; Plotz G; Zeuzem S; Brieger A
    Int J Oncol; 2020 Jun; 56(6):1551-1564. PubMed ID: 32236629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MSH3 mismatch repair protein regulates sensitivity to cytotoxic drugs and a histone deacetylase inhibitor in human colon carcinoma cells.
    Park JM; Huang S; Tougeron D; Sinicrope FA
    PLoS One; 2013; 8(5):e65369. PubMed ID: 23724141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
    Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interdependence of DNA mismatch repair proteins MLH1 and MSH2 in apoptosis in human colorectal carcinoma cell lines.
    Hassen S; Ali AA; Kilaparty SP; Al-Anbaky QA; Majeed W; Boman BM; Fields JZ; Ali N
    Mol Cell Biochem; 2016 Jan; 412(1-2):297-305. PubMed ID: 26728996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting mitochondrial DNA polymerase gamma for selective inhibition of MLH1 deficient colon cancer growth.
    Somuncu B; Ekmekcioglu A; Antmen FM; Ertuzun T; Deniz E; Keskin N; Park J; Yazici IE; Simsek B; Erman B; Yin W; Erman B; Muftuoglu M
    PLoS One; 2022; 17(6):e0268391. PubMed ID: 35657956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells.
    Berry SE; Garces C; Hwang HS; Kunugi K; Meyers M; Davis TW; Boothman DA; Kinsella TJ
    Cancer Res; 1999 Apr; 59(8):1840-5. PubMed ID: 10213489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of MLH1 sensitizes colon cancer cells to DNA-PKcs inhibitor KU60648.
    Hinrichsen I; Ackermann A; Düding T; Graband A; Filmann N; Plotz G; Zeuzem S; Brieger A
    Mol Carcinog; 2017 Jul; 56(7):1816-1824. PubMed ID: 28224663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSH3 expression does not influence the sensitivity of colon cancer HCT116 cell line to oxaliplatin and poly(ADP-ribose) polymerase (PARP) inhibitor as monotherapy or in combination.
    Tentori L; Muzi A; Dorio AS; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):117-25. PubMed ID: 23636450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical detection of ARID1A in colorectal carcinoma: loss of staining is associated with sporadic microsatellite unstable tumors with medullary histology and high TNM stage.
    Ye J; Zhou Y; Weiser MR; Gönen M; Zhang L; Samdani T; Bacares R; DeLair D; Ivelja S; Vakiani E; Klimstra DS; Soslow RA; Shia J
    Hum Pathol; 2014 Dec; 45(12):2430-6. PubMed ID: 25311944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
    Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
    [No Abstract]   [Full Text] [Related]  

  • 13. Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation.
    Davis TW; Wilson-Van Patten C; Meyers M; Kunugi KA; Cuthill S; Reznikoff C; Garces C; Boland CR; Kinsella TJ; Fishel R; Boothman DA
    Cancer Res; 1998 Feb; 58(4):767-78. PubMed ID: 9485033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FANCJ expression predicts the response to 5-fluorouracil-based chemotherapy in MLH1-proficient colorectal cancer.
    Nakanishi R; Kitao H; Fujinaka Y; Yamashita N; Iimori M; Tokunaga E; Yamashita N; Morita M; Kakeji Y; Maehara Y
    Ann Surg Oncol; 2012 Oct; 19(11):3627-35. PubMed ID: 22526901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoskeletal scaffolding proteins interact with Lynch-Syndrome associated mismatch repair protein MLH1.
    Brieger A; Adryan B; Wolpert F; Passmann S; Zeuzem S; Trojan J
    Proteomics; 2010 Sep; 10(18):3343-55. PubMed ID: 20706999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers.
    Müller A; Zielinski D; Friedrichs N; Oberschmid B; Merkelbach-Bruse S; Schackert HK; Linnebacher M; von Knebel Doeberitz M; Büttner R; Rüschoff J;
    Virchows Arch; 2008 Jul; 453(1):9-16. PubMed ID: 18581137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.
    Buchanan DD; Tan YY; Walsh MD; Clendenning M; Metcalf AM; Ferguson K; Arnold ST; Thompson BA; Lose FA; Parsons MT; Walters RJ; Pearson SA; Cummings M; Oehler MK; Blomfield PB; Quinn MA; Kirk JA; Stewart CJ; Obermair A; Young JP; Webb PM; Spurdle AB
    J Clin Oncol; 2014 Jan; 32(2):90-100. PubMed ID: 24323032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of MLH1 on colon cancer sensitivity to poly(ADP-ribose) polymerase inhibitor combined with irinotecan.
    Tentori L; Leonetti C; Muzi A; Dorio AS; Porru M; Dolci S; Campolo F; Vernole P; Lacal PM; Praz F; Graziani G
    Int J Oncol; 2013 Jul; 43(1):210-8. PubMed ID: 23653048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLH1 deficiency enhances tumor cell sensitivity to ganciclovir.
    O'Konek JJ; Boucher PD; Iacco AA; Wilson TE; Shewach DS
    Cancer Gene Ther; 2009 Sep; 16(9):683-92. PubMed ID: 19300472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An MLH1 mutation links BACH1/FANCJ to colon cancer, signaling, and insight toward directed therapy.
    Xie J; Guillemette S; Peng M; Gilbert C; Buermeyer A; Cantor SB
    Cancer Prev Res (Phila); 2010 Nov; 3(11):1409-16. PubMed ID: 20978114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.